Seeking co-development and collaborative innovation projects in therapeutics, consumer health, and AI-driven bioactive discovery

Alphanosos is seeking partners for collaborative innovation and co-development projects that combine artificial intelligence, experimental biology, and natural biodiversity to address major health and sustainability challenges.

Our proprietary discovery platform enables the identification of novel bioactive compositions with applications in infectious diseases, chronic inflammatory disorders, oncology, neurological and metabolic diseases, rare genetic conditions, consumer health, cosmetics, and animal health. The platform has already generated patented assets with preclinical and clinical validation and continues to expand into new therapeutic areas.

We are interested in collaborative research projects, clinical validation programs, public-private partnerships, international consortia, co-funded innovation initiatives, and translational development projects. We welcome collaborations with pharmaceutical and biotechnology companies, hospitals, academic institutions, research organizations, foundations, public agencies, and corporate innovation teams.

Through these partnerships, we aim to accelerate the development of innovative, sustainable, and impactful health solutions while sharing expertise, resources, and scientific capabilities to address unmet medical and societal needs.